Learn More
Medchemexpress LLC CE3F4 | 143703-25-7 | 98.9% | 351.01 | 1 ML

Supplier: Medchemexpress LLC HY108539100MG
CE3F4 is a selective antagonist of exchange protein directly activated by cAMP (Epac1), with higher activity against Epac1 than Epac2(B). It effectively reduces the exchange activity of Epac1. This compound offers a targeted approach for studying Epac1-mediated pathways.
- Selective antagonist of Epac1.
- Inhibits Epac1 guanine nucleotide exchange activity.
- Does not interfere with Rap1 activity or Epac1-Rap1 interaction.
- No influence on PKA activity.
- Inhibits Epac-induced Rap1 activation in cultured HEK293 cells.
- Significantly inhibits the late phase of ERK activation stimulated by glucose in INS-1 cells.
- Inhibits atrial fibrillation and ventricular arrhythmias in animal models.
- Improves cardiac function after myocardial infarction in mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.